SAFE vs Priced Round: How to Choose

Somewhere in every early raise, an investor asks "SAFE or priced?" and the founder answers with whatever they heard last. It is treated as paperwork trivia — a lawyer question, settled by whichever template is nearest.

It is not trivia. The instrument decides how fast money can land, what the round costs in legal fees, when your valuation gets set, what rights investors hold, and — the one that bites hardest — whether you actually know your own dilution or merely have a feeling about it. Founders have signed away a fifth of their company across a stack of SAFEs and only learned the total at the Series A, when every one of them converted at once.

This guide explains both instruments plainly, compares them side by side, and gives you the honest decision logic. It is one chapter of the fundraising process guide; the stage guides for pre-seed and seed cover where each instrument shows up in the wild.

Raise smarter with Raised — Raised's term-sheet builder and pipeline keep every instrument, cap and cheque in one place, so the cap-table maths is never a surprise.

What a SAFE is

A SAFE — Simple Agreement for Future Equity — is a short standard contract, open-sourced by Y Combinator in 2013: the investor wires money now and receives the right to shares later, when a priced round happens. No shares change hands today, no valuation is negotiated today, and there is no interest or maturity date (which is what separates it from a convertible note).

Instead of a price, a SAFE carries one or both of:

• A valuation cap — the maximum valuation at which the investment converts. Cap of 5m, next round priced at 10m: the SAFE holder converts as if the company were worth 5m, getting roughly twice the shares their money would buy at the round price.
• A discount — a percentage off the next round's price, commonly in the 10–20% region. Where both exist, the investor gets whichever is better for them.

Since 2018 the standard YC document is the post-money SAFE, whose cap includes the SAFE money itself — its virtue is that each holder's ownership is knowable the day they sign, and the corresponding vice is that the dilution from every SAFE lands squarely on the founders and existing shareholders, not on the other SAFE holders. That makes the maths honest, provided you actually do it.

What a priced round is

A priced round is the classical equity financing: you negotiate a valuation now, issue new shares now, and the investor becomes a shareholder on the day of closing. The paperwork is the full venture stack — share purchase agreement, amended articles, investor rights — typically descended from the NVCA model documents, negotiated by lawyers on both sides.

With the price comes structure: liquidation preference (1x non-participating is standard; hold that line), pro-rata rights, protective provisions over major decisions, usually an enlarged option pool, and — at Series A, sometimes at larger seeds — a board seat for the lead. Closing is a single event: everyone signs the same documents, and from signed term sheet to money is typically several weeks of legal work.

Side by side

A worked example

Numbers make the SAFE mechanics concrete. Say an angel puts 100k on a post-money SAFE with a 5m cap. Eighteen months later you raise a priced seed at a 10m pre-money valuation.

The cap is lower than the round's effective price, so the SAFE converts at the cap: the angel's 100k buys 2% of the company (100k over the 5m post-money cap), roughly double what the same money would buy at the round price. If the SAFE had carried a 20% discount instead of a cap, they would convert at 80% of the round's share price. If it carried both, they would get whichever is better for them — here, the cap.

Now run the same arithmetic across a real stack: five SAFEs at three different caps signed over two years. Each one converts by its own terms, in the same round, on top of the new investors' stake and the enlarged option pool. That is the calculation the dilution calculator exists for, and the reason to run it before each signature rather than once at the end.

What about convertible notes?

The SAFE's older sibling deserves a paragraph. A convertible note is debt that converts to equity — like a SAFE it defers pricing with a cap and/or discount, but unlike a SAFE it accrues interest and carries a maturity date, a deadline by which it must convert, be repaid or be renegotiated. That maturity date is the practical difference: it hands the investor a lever at an awkward moment, and it is a large part of why the SAFE has displaced the note across most early-stage rounds since 2013. Notes still appear — some investors prefer them, and some jurisdictions handle them more cleanly — but if you are choosing freely, the SAFE is the simpler instrument, and everything in this guide's comparison applies to notes with "plus interest, plus a deadline" appended.

The stacking problem

The SAFE's speed hides its one real trap: SAFEs are invisible until they all become visible at once.

Each individual SAFE feels small. A hundred thousand here at one cap, a quarter million there at another, a bridge six months later at a third. None of them touches the cap table today, so the cap table keeps looking clean. Then the priced round arrives, every SAFE converts simultaneously — each at its own cap or discount — and the combined dilution lands in one lump, right when new investors are also taking their 15–25% and the option pool is being enlarged. Founders who never summed the stack discover their post-A ownership is ten points below what they had assumed, and there is no renegotiating a signed SAFE.

The defence is arithmetic, done early and repeated every time you sign one more. The dilution calculator models a cap or a priced round and shows your stake after conversion; keeping every SAFE's cap, discount and amount logged in one place — Raised does this as part of the pipeline — means the running total is a glance, not an archaeology project at term-sheet time.

How to choose

The honest logic, in order:

Stage usually decides it. At pre-seed, SAFEs are close to universal — the amounts do not justify priced-round legal fees, and rolling closes suit angel money. At Series A, priced rounds are close to universal — the amounts and the board seat demand real structure. Seed is the genuine fork, and there the next rule applies.

The lead's preference matters more than yours. A strong lead who wants a priced seed with a board seat is not worth losing over instrument preference; a round of angels and small funds with no lead all but requires SAFEs, since there is nobody to negotiate a price with.

Speed and cost favour the SAFE. If the money is needed soon and the round is many small cheques, rolling SAFE closes get you funded weeks earlier and thousands cheaper.

Certainty favours the priced round. If you want your dilution known, your investor base formalised and your next raise arithmetically clean, price it now and pay the legal bill.

Whatever you choose, keep it boring. One document, one cap, identical terms for everyone in the round. A spread of side deals — different caps for different friends, a discount here, an MFN clause there — reads as chaos in the next round's diligence, because it is.

And if the deeper question is really "which round am I raising at all?", that is the round picker's job.

Put it together

A SAFE is deferred pricing: fast, cheap, rolling, and silent about dilution until everything converts at once. A priced round is present pricing: slower, costlier, structured, and honest on day one. Pre-seed takes SAFEs, the A takes priced equity, and seed goes to whoever leads. The only unforgivable move is not doing the maths — sum the stack every time you sign, model the conversion before the caps are set, and walk into your priced round already knowing what it will show.

Raise smarter with Raised. Every SAFE, cap and commitment logged against the investor who signed it, a term-sheet builder for when the round gets priced, and an AI assistant that has actually read your documents.